Chemours

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemours overcomes Q4 challenges, eyes growth and sustainability in 2023

Chemours had a tough Q4 but a successful year overall, with a focus on margin improvement, growth in key businesses, and addressing legacy issues. The company is optimistic about 2023, emphasizing sustainability-led growth and returning value to shareholders.

Chemours reports strong Q1 performance, navigates challenges, eyes growth opportunities

Chemours' Q1 2023 Earnings Call highlighted strong performance, reaffirmed guidance, and emphasized margin improvement strategies. The company faces challenges from macroeconomic uncertainties and inflationary pressures but sees opportunities in sustainable initiatives and market-led innovation. Chemours remains confident in its full-year outlook and growth strategies.

Chemours reports record results, eyes cost reduction and innovation

Chemours had a strong quarter with record results and notable achievements in facility closures and settlements. While challenges lie ahead with a weaker second half expected, the company remains focused on shareholder value and strategic priorities. Opportunities in cost reduction, innovation, and market leadership position Chemours for future growth.

Chemours addresses challenges, eyes growth in sustainable solutions market

Chemours Company navigated challenges in Q3 2023, with a focus on long-term shareholder value and strategic transformation for performance improvement.
Strong performance in Performance Solutions and TSS business, alongside cost savings initiatives, position Chemours for future growth and margin recovery.
Management's commitment to driving value for shareholders amidst industry challenges underscores a proactive approach to addressing market dynamics.

Chemours reports Q4 sales growth, addresses TiO2 market challenges

Chemours is navigating challenges in the TiO2 market while focusing on cost reduction and growth opportunities in other segments. The company aims to maintain competitiveness through strategic decisions and investments in R&D. Analysts' inquiries during the earnings call highlighted concerns about leadership stability and various segment dynamics.

Chemours reports mixed Q1 results, eyes sequential growth in 2024

Chemours' Q1 2024 performance reflected mixed results across segments, with a focus on cost efficiencies, transformation plans, and maintaining liquidity amidst declining net sales and EBITDA.
Despite challenges in certain segments and market uncertainties, Chemours remains optimistic about sequential growth in the second quarter, aiming for significant EBITDA potential in 2024 and long-term financial improvement.
Strategic strengths in cost management, growth initiatives, and market opportunities position Chemours to navigate challenges, drive growth, and enhance profitability in a dynamic business environment.

Chemours exceeds volume expectations amidst challenges, anticipates sequential decline

Chemours demonstrated resilience and growth in key product lines despite facing challenges in Q1 and Q2.
The company's cost-saving efforts and recovery in certain segments highlight its ability to adapt to market conditions.
While financial results were impacted by one-time costs and a decline in net sales, Chemours maintained a strong net leverage ratio.
Anticipated sequential decline in net sales for Q3 underscores the need for strategic planning and operational optimization.

Chemours reports strong Q3 performance amidst strategic growth initiatives

Chemours' Q3 performance reflects operational strength and growth in key segments.
Challenges include declines in net sales for TSS and TT in Q4 and a net loss.
Opportunities exist in cost savings, growth in Opteon refrigerants, and strategic investments.
Overall, Chemours remains confident in its strategy to drive shareholder value.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

Chemours Company (CC) CEO Mark Vergnano on Q2 2019 Results - Earnings Call Transcript

Weak demand for Ti-Pure TiO2 and Illegal imports of HFC refrigerants hurt Chemours (CC) in Q2.

Chemours' (CC) Earnings and Revenues Miss Estimates in Q2

Chemours (CC) delivered earnings and revenue surprises of -20.00% and -7.97%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Chemours (CC) Q2 Earnings and Revenues Lag Estimates

Chemours Co. CC, -4.77% shares fell more than 5% in the extended session Thursday after the chemical company spun off Dupont reported second-quarter results that missed expectations and lowered its outlook for the year, pinning it on its quarterly performance and "increasing macroeconomic uncertainty.

Chemours stock falls after company's Q2 miss, lowered outlook

On Thursday, August 1, Chemours (NYSE: CC) will report its last quarter's earnings.

Q2 Earnings Outlook For Chemours

Scientific Games

Dillard's

Hedge fund Greenlight Capital has added new positions in Dillard's, Inc. (NYSE: DDS), Chemours Co (NYSE: CC) and Scientific Games Corp (NASDAQ: SGMS), president David Einhorn said in his second-quarter letter to investors.

David Einhorn's Q2 Letter To Greenlight Investors Shows New Stakes In Dillards, Chemours, Scientific Games

David Einhorn revealed on Thursday new positions in three stocks: Chemours, Dillard’s and Scientific Games.

David Einhorn reveals new positions in Chemours, Dillard's and Scientific Games

Cigna

Marathon Petroleum

Pure Storage

Six Flags

TripAdvisor

CNBC combed through Wall Street research over the last week to see which stocks analysts say to look at in the second half of the year.

These stocks are second-half comeback stories, according to Wall Street analysts

Bristol-Myers

Black Stone Minerals LP

Kroger

Sprouts Farmers Markets

Simon Property Group

Details the lows for the following companies: Bristol-Myers Squibb, Simon Property Group, Kroger, The Chemours Co., Black Stone Minerals and Sprouts Farmers Market.

52-Week Company Lows (July 7)

Chemours' (CC) new Texas-based facility will triple its production capacity of Opteon YF, which minimizes greenhouse gases.

Chemours Inaugurates Opteon Facility, Boosts Production

Recent data indicates that Chemours Co (NYSE: CC) faces challenges in several end markets, suggesting the company’s rebound in the second half of this year could be slower than expected, according to BMO Capital Markets.

BMO: Chemours' Second Half 'More Difficult Than Anticipated'

Guess?

Odonate Therapeutics

Intrexon

Details the CEO buys this past week for the following companies: Guess?, Intrexon, Odonate Therapeutics, The Chemours and i3 Verticals

Weekly CEO Buys Highlight June 17

President and CEO of The Chemours Co (NYSE:CC) Mark P Vergnano bought 44,000 shares of CC on 06/10/2019 at an average price of $23.17 a share.

The Chemours Co President and CEO Bought $1 million of Shares

The market misunderstands Chemours as a typical toxic chemical business - when it should focus on its strong and defensible moats.

The Chemours Company: Quality Business At Attractive Prices Due To Industry's Cyclical Bottom

The Chemours Co (CC) President and CEO Mark P Vergnano Bought $1 million of Shares

The materials science company reported weak quarterly results, but environmental pollution risks are also piling up.

Here's Why Chemours Tumbled 41.4% in May

Chemours Co. said late Tuesday it named Mark Newman to the newly created role of chief operating officer, and promoted its vice president of business finance and treasurer Sameer Ralhan to chief financial officer and treasurer.

Chemours names new COO, CFO

Chemours (CC) reported earnings 30 days ago. What's next for the stock?

Chemours (CC) Down 35% Since Last Earnings Report: Can It Rebound?

Chemours' (CC) Opteon XL41 is an A2L class refrigerant that offers the lowest GWP replacement solution.

Chemours' Opteon Refrigerants Selected by MEHITS Applications

Chemours Co stock traded higher by more than 7 percent on Tuesday after selling off by 8 percent over the previous week.

Option Traders Making Aggressive Bullish Plays On Chemours

Lower volumes in the Titanium Technologies unit and higher costs hurt Chemours' (CC) Q1 results.

Chemours' (CC) Earnings, Revenues Trail Estimates in Q1

Affiliated Managers

PetMed Express

Earnings, analysts, and other concerns hurt these stocks.

Why PetMed Express, Chemours, and Affiliated Managers Group Slumped Today

Chemours Co guided to a sharp year-on-year decline in titanium dioxide volumes in the second quarter.

Chemours' 35% Drop In Titanium Dioxide Volume Sends JPMorgan To Sidelines

Aflac

Ally Financial

Valvoline

Wendy's

We retirees and soon-to-be retirees have a dilemma.

5 Dividend Growers That'll Double Your Retirement Savings

The Chemours' (CC) CEO Mark Vergnano on Q4 2018 Results - Earnings Call Transcript

News for Chemours Stock (CC)